What’s Militia Hill Ventures’ take on biotech, cancer therapy investment? (Q&A)
Jane Holmes Hollingsworth, Militia Hill Ventures cofounder and managing partner, will take part in a panel discussion on investment in cancer therapies at the MedCity CONVERGE conference in Philadelphia July 31-August 1.